| ACH-ALENDRONATE (10 MG)Accord Healthcare Inc · Status since Mar 2012 | 02381486 | Marketed | Accord Healthcare Inc | Mar 2012 |
| ACH-ALENDRONATE (70 MG)Accord Healthcare Inc · Status since Mar 2012 | 02381494 | Marketed | Accord Healthcare Inc | Mar 2012 |
| AG-ALENDRONATE SODIUM (70 MG)Angita Pharma Inc. · Status since Apr 2024 | 02506327 | Marketed | Angita Pharma Inc. | Apr 2024 |
| ALENDRONATE (70 MG)Sivem Pharmaceuticals Ulc · Status since Jan 2022 | 02299712 | Marketed | Sivem Pharmaceuticals Ulc | Jan 2022 |
| ALENDRONATE (70 MG)Sanis Health Inc. · Status since Feb 2026 | 02352966 | Marketed | Sanis Health Inc. | Feb 2026 |
| ALENDRONATE-70 (70 MG)Pro Doc Limitee · Status since Jan 2024 | 02303078 | Marketed | Pro Doc Limitee | Jan 2024 |
| APO-ALENDRONATE (70 MG)Apotex Inc. · Status since May 2005 | 02248730 | Marketed | Apotex Inc. | May 2005 |
| APO-ALENDRONATE/VITAMIN D3 (70 MG)Apotex Inc. · Status since Jul 2016 | 02454467 | Marketed | Apotex Inc. | Jul 2016 |
| APO-ALENDRONATE/VITAMIN D3 (70 MG)Apotex Inc. · Status since Jul 2016 | 02454475 | Marketed | Apotex Inc. | Jul 2016 |
| AURO-ALENDRONATE (10 MG)Auro Pharma Inc. · Status since Jul 2012 | 02388545 | Marketed | Auro Pharma Inc. | Jul 2012 |
| AURO-ALENDRONATE (70 MG)Auro Pharma Inc. · Status since Jul 2012 | 02388553 | Marketed | Auro Pharma Inc. | Jul 2012 |
| FOSAMAX (70 MG)Organon Canada Inc. · Status since May 2022 | 02245329 | Marketed | Organon Canada Inc. | May 2022 |
| FOSAVANCE (70 MG)Organon Canada Inc. · Status since Jun 2022 | 02276429 | Marketed | Organon Canada Inc. | Jun 2022 |
| FOSAVANCE (70 MG)Organon Canada Inc. · Status since Jul 2022 | 02314940 | Marketed | Organon Canada Inc. | Jul 2022 |
| JAMP ALENDRONATE / VITAMIN D3 (70 MG)JAMP Pharma Corporation · Status since Jun 2023 | 02519828 | Marketed | JAMP Pharma Corporation | Jun 2023 |
| JAMP ALENDRONATE / VITAMIN D3 (70 MG)JAMP Pharma Corporation · Status since Mar 2023 | 02519836 | Marketed | JAMP Pharma Corporation | Mar 2023 |
| JAMP ALENDRONATE SODIUM (70 MG)JAMP Pharma Corporation · Status since Jul 2022 | 02500175 | Marketed | JAMP Pharma Corporation | Jul 2022 |
| M-ALENDRONATE (70 MG)Mantra Pharma Inc. · Status since Jun 2026 | 02529394 | Marketed | Mantra Pharma Inc. | Jun 2026 |
| NRA-ALENDRONATE (70 MG)Nora Pharma Inc. · Status since Aug 2022 | 02523116 | Marketed | Nora Pharma Inc. | Aug 2022 |
| PMS-ALENDRONATE-FC (70 MG)Pharmascience Inc. · Status since Aug 2006 | 02284006 | Marketed | Pharmascience Inc. | Aug 2006 |
| RIVA-ALENDRONATE (70 MG)Laboratoire Riva Inc. · Status since Dec 2025 | 02270889 | Marketed | Laboratoire Riva Inc. | Dec 2025 |
| TEVA-ALENDRONATE (70 MG)Teva Canada Limited · Status since Jun 2010 | 02261715 | Marketed | Teva Canada Limited | Jun 2010 |
| ACH-ALENDRONATE (5 MG)Accord Healthcare Inc · Status since Sep 2026 | 02381478 | Dormant | Accord Healthcare Inc | Sep 2026 |
| AG-ALENDRONATE (5 MG)Angita Pharma Inc. · Status since Jan 2019 | 02485168 | Approved | Angita Pharma Inc. | Jan 2019 |
| AG-ALENDRONATE (10 MG)Angita Pharma Inc. · Status since Jan 2019 | 02485176 | Approved | Angita Pharma Inc. | Jan 2019 |
| AG-ALENDRONATE (70 MG)Angita Pharma Inc. · Status since Jul 2025 | 02485184 | Dormant | Angita Pharma Inc. | Jul 2025 |
| ALENDRONATE (5 MG)Sanis Health Inc. · Status since Dec 2021 | 02523159 | Approved | Sanis Health Inc. | Dec 2021 |
| ALENDRONATE (10 MG)Sanis Health Inc. · Status since Dec 2021 | 02523167 | Approved | Sanis Health Inc. | Dec 2021 |
| ALENDRONATE-10 (10 MG)Pro Doc Limitee · Status since Jan 2024 | 02544288 | Approved | Pro Doc Limitee | Jan 2024 |
| ALENDRONATE-40 (40 MG)Pro Doc Limitee · Status since Jan 2024 | 02544296 | Approved | Pro Doc Limitee | Jan 2024 |
| ALENDRONATE-5 (5 MG)Pro Doc Limitee · Status since Jan 2024 | 02544261 | Approved | Pro Doc Limitee | Jan 2024 |
| APO-ALENDRONATE (5 MG)Apotex Inc. · Status since Jul 2021 | 02248727 | Dormant | Apotex Inc. | Jul 2021 |
| APO-ALENDRONATE (10 MG)Apotex Inc. · Status since Mar 2021 | 02248728 | Dormant | Apotex Inc. | Mar 2021 |
| APO-ALENDRONATE (40 MG)Apotex Inc. · Status since Feb 2004 | 02248729 | Approved | Apotex Inc. | Feb 2004 |
| JAMP-ALENDRONATE (5 MG)JAMP Pharma Corporation · Status since May 2012 | 02385015 | Approved | JAMP Pharma Corporation | May 2012 |
| JAMP-ALENDRONATE (10 MG)JAMP Pharma Corporation · Status since May 2012 | 02385023 | Approved | JAMP Pharma Corporation | May 2012 |
| JAMP-ALENDRONATE (70 MG)JAMP Pharma Corporation · Status since Jul 2024 | 02385031 | Dormant | JAMP Pharma Corporation | Jul 2024 |
| M-ALENDRONATE (10 MG)Mantra Pharma Inc. · Status since Nov 2025 | 02529408 | Approved | Mantra Pharma Inc. | Nov 2025 |
| MINT-ALENDRONATE (5.0 MG)Mint Pharmaceuticals Inc · Status since Oct 2012 | 02394855 | Approved | Mint Pharmaceuticals Inc | Oct 2012 |
| MINT-ALENDRONATE (70.0 MG)Mint Pharmaceuticals Inc · Status since Sep 2025 | 02394871 | Dormant | Mint Pharmaceuticals Inc | Sep 2025 |
| NB-ALENDRONATE-FC (70 MG)NB Pharma Inc. · Status since Jan 2026 | 02564335 | Approved | NB Pharma Inc. | Jan 2026 |
| NRA-ALENDRONATE (5 MG)Nora Pharma Inc. · Status since Dec 2021 | 02523094 | Approved | Nora Pharma Inc. | Dec 2021 |
| NRA-ALENDRONATE (10 MG)Nora Pharma Inc. · Status since Dec 2021 | 02523108 | Approved | Nora Pharma Inc. | Dec 2021 |
| PMS-ALENDRONATE (70 MG)Pharmascience Inc. · Status since Aug 2017 | 02273179 | Dormant | Pharmascience Inc. | Aug 2017 |
| RIVA-ALENDRONATE (10 MG)Laboratoire Riva Inc. · Status since Dec 2025 | 02476401 | Approved | Laboratoire Riva Inc. | Dec 2025 |
| TEVA-ALENDRONATE/CHOLECALCIFEROL (70 MG)Teva Canada Limited · Status since Jun 2020 | 02403633 | Dormant | Teva Canada Limited | Jun 2020 |
| TEVA-ALENDRONATE/CHOLECALCIFEROL (70 MG)Teva Canada Limited · Status since Jun 2020 | 02403641 | Dormant | Teva Canada Limited | Jun 2020 |
| ACCEL-ALENDRONATE (5 MG)Accel Pharma Inc · Status since Sep 2017 | 02401118 | Cancelled Pre Market | Accel Pharma Inc | Sep 2017 |
| ACCEL-ALENDRONATE (10 MG)Accel Pharma Inc · Status since Sep 2017 | 02401126 | Cancelled Post Market | Accel Pharma Inc | Sep 2017 |
| ACCEL-ALENDRONATE (70 MG)Accel Pharma Inc · Status since Sep 2017 | 02401134 | Cancelled Post Market | Accel Pharma Inc | Sep 2017 |
| ACT ALENDRONATE (40 MG)Actavis Pharma Company · Status since Jul 2019 | 02258102 | Cancelled Post Market | Actavis Pharma Company | Jul 2019 |
| ACT ALENDRONATE (70 MG)Actavis Pharma Company · Status since Jun 2018 | 02258110 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ALENDRONATE (70 MG)Sorres Pharma Inc · Status since Jun 2014 | 02302004 | Cancelled Post Market | Sorres Pharma Inc | Jun 2014 |
| ALENDRONATE (40 MG)Cobalt Pharmaceuticals Incorporated · Status since Sep 2017 | 02343916 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| ALENDRONATE (70 MG)Cobalt Pharmaceuticals Incorporated · Status since Sep 2017 | 02343924 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| ALENDRONATE-CHOLECALCIFEROL (70 MG)Frosst A Division Of Merck Canada Inc · Status since May 2016 | 02405717 | Cancelled Pre Market | Frosst A Division Of Merck Canada Inc | May 2016 |
| ALENDRONATE-CHOLECALCIFEROL (70 MG)Frosst A Division Of Merck Canada Inc · Status since May 2016 | 02405725 | Cancelled Pre Market | Frosst A Division Of Merck Canada Inc | May 2016 |
| AVA-ALENDRONATE (5 MG)Avanstra Inc · Status since Dec 2021 | 02365057 | Cancelled (Unreturned Annual) | Avanstra Inc | Dec 2021 |
| AVA-ALENDRONATE (10 MG)Avanstra Inc · Status since Dec 2021 | 02365065 | Cancelled (Unreturned Annual) | Avanstra Inc | Dec 2021 |
| AVA-ALENDRONATE (40 MG)Avanstra Inc · Status since Dec 2021 | 02365073 | Cancelled (Unreturned Annual) | Avanstra Inc | Dec 2021 |
| AVA-ALENDRONATE (70 MG)Avanstra Inc · Status since Dec 2021 | 02365081 | Cancelled (Unreturned Annual) | Avanstra Inc | Dec 2021 |
| DOM-ALENDRONATE (70 MG)Dominion Pharmacal · Status since May 2025 | 02282763 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| DOM-ALENDRONATE-FC (70 MG)Dominion Pharmacal · Status since May 2025 | 02308398 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| FOSAMAX (40 MG)Merck Canada Inc · Status since Jul 2013 | 02201038 | Cancelled Post Market | Merck Canada Inc | Jul 2013 |
| FOSAMAX (10 MG)Merck Canada Inc · Status since Nov 2011 | 02201011 | Cancelled Post Market | Merck Canada Inc | Nov 2011 |
| FOSAMAX (5 MG)Merck Canada Inc · Status since Jul 2010 | 02233055 | Cancelled Post Market | Merck Canada Inc | Jul 2010 |
| FOSAMAX (70 MG)Merck Canada Inc · Status since Jul 2013 | 02248625 | Cancelled Post Market | Merck Canada Inc | Jul 2013 |
| GEN-ALENDRONATE (5 MG)Genpharm Inc. · Status since Aug 2009 | 02270110 | Cancelled Post Market | Genpharm Inc. | Aug 2009 |
| M-ALENDRONATE (5 MG)Mantra Pharma Inc. · Status since Dec 2025 | 02529416 | Cancelled Pre Market | Mantra Pharma Inc. | Dec 2025 |
| MINT-ALENDRONATE (10.0 MG)Mint Pharmaceuticals Inc · Status since Aug 2018 | 02394863 | Cancelled Post Market | Mint Pharmaceuticals Inc | Aug 2018 |
| MYLAN-ALENDRONATE (10 MG)Mylan Pharmaceuticals Ulc · Status since Sep 2017 | 02270129 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Sep 2017 |
| MYLAN-ALENDRONATE (70 MG)Mylan Pharmaceuticals Ulc · Status since Jul 2018 | 02286335 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jul 2018 |
| PHL-ALENDRONATE (70 MG)Pharmel Inc. · Status since Oct 2016 | 02282771 | Cancelled Post Market | Pharmel Inc. | Oct 2016 |
| Q-ALENDRONATE (70 MG)Qd Pharmaceuticals Ulc · Status since Aug 2015 | 02372304 | Cancelled Post Market | Qd Pharmaceuticals Ulc | Aug 2015 |
| RAN-ALENDRONATE (5 MG)Ranbaxy Pharmaceuticals Canada Inc. · Status since Sep 2022 | 02384698 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Sep 2022 |
| RAN-ALENDRONATE (10 MG)Ranbaxy Pharmaceuticals Canada Inc. · Status since Sep 2022 | 02384701 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Sep 2022 |
| RAN-ALENDRONATE (70 MG)Ranbaxy Pharmaceuticals Canada Inc. · Status since Sep 2022 | 02384728 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Sep 2022 |
| RATIO ALENDRONATE (70 MG)Ratiopharm Inc Division Of Teva Canada Limited · Status since Sep 2014 | 02275279 | Cancelled Post Market | Ratiopharm Inc Division Of Teva Canada Limited | Sep 2014 |
| RIVA ALENDRONATE (40 MG)Laboratoire Riva Inc. · Status since Sep 2016 | 02270870 | Cancelled Pre Market | Laboratoire Riva Inc. | Sep 2016 |
| RIVA ALENDRONATE (70 MG)Laboratoire Riva Inc. · Status since Jul 2026 | 02549387 | Cancelled Pre Market | Laboratoire Riva Inc. | Jul 2026 |
| RIVA-ALENDRONATE (5 MG)Laboratoire Riva Inc. · Status since Jul 2026 | 02476398 | Cancelled Pre Market | Laboratoire Riva Inc. | Jul 2026 |
| SANDOZ ALENDRONATE (5 MG)Sandoz Canada Inc. · Status since Aug 2016 | 02288079 | Cancelled Post Market | Sandoz Canada Inc. | Aug 2016 |
| SANDOZ ALENDRONATE (10 MG)Sandoz Canada Inc. · Status since Dec 2019 | 02288087 | Cancelled Post Market | Sandoz Canada Inc. | Dec 2019 |
| SANDOZ ALENDRONATE (40 MG)Sandoz Canada Inc. · Status since Aug 2016 | 02288095 | Cancelled Pre Market | Sandoz Canada Inc. | Aug 2016 |
| SANDOZ ALENDRONATE (70 MG)Sandoz Canada Inc. · Status since Jul 2026 | 02288109 | Cancelled Post Market | Sandoz Canada Inc. | Jul 2026 |
| SANDOZ ALENDRONATE/CHOLECALCIFEROL (70 MG)Sandoz Canada Inc. · Status since Jul 2023 | 02429160 | Cancelled Post Market | Sandoz Canada Inc. | Jul 2023 |
| TEVA-ALENDRONATE (10 MG)Teva Canada Limited · Status since Jul 2021 | 02247373 | Cancelled Post Market | Teva Canada Limited | Jul 2021 |
| TEVA-ALENDRONATE (5 MG)Teva Canada Limited · Status since Jul 2021 | 02248251 | Cancelled Post Market | Teva Canada Limited | Jul 2021 |
| VAN-ALENDRONATE (5 MG)Vanc Pharmaceuticals Inc · Status since Aug 2019 | 02428717 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |
| VAN-ALENDRONATE (10 MG)Vanc Pharmaceuticals Inc · Status since Aug 2019 | 02428725 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |
| VAN-ALENDRONATE (70 MG)Vanc Pharmaceuticals Inc · Status since Aug 2019 | 02428733 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |